Xir xayeysiis

Samsung ayuu ku dhawaaqay, in IHRN (Ogaysiinta laxanka Wadnaha ee aan joogtada ahayn) ee qaybta ECG ee jirta Galaxy Watch ogolaansho ka helay US FDA (Maamulka Cunnada iyo Dawooyinka). Isticmaalayaasha Galaxy Watch s Wear OS-yadu waxay dhawaan awoodi doonaan inay isticmaalaan dareeraha BioActive si ay u raadiyaan calaamadaha fibrillada atrial.

Samsung ayaa sheegtay in sifada IHRN ee ay FDA ogolaatay ay ka soo muuqan doonto saacada Galaxy Watch6, oo ay tahay inuu soo bandhigo xagaaga. Galaxy Watch6 ayaa sida muuqata ka koobnaan doona moodal caadi ah iyo nooc Classic ah, kaas oo ah in uu lahaado wareegyo jireed lunette.

Kooxda Kuuriya ayaa intaa ku dartay in muuqaalkan, kaas oo hubin doona garaaca wadnaha ee aan caadiga ahayn ee gadaasha iyadoo la adeegsanayo dareeraha BioActive marka la furo app-ka Samsung Health Monitor, ayaa hadhow lagu kordhin doonaa saacadaha hore. Galaxy Watch Dareemkan, kuwaas oo saf ah Galaxy Watch4 in Watch5. Faahfaahinta helitaankan waxa sidoo kale lagu xaqiijiyay cusboonaysiinta soo socota ee One UI 5 Watch, kaas oo ku iman doona oo keliya saacadaha nidaamka leh Wear OS, ma aha moodooyinka ku shaqeeya Tizen ee da'da ah sida Galaxy Watch3.

Sida laga soo xigtay dhawaanahan Samsung leaks, taxanaha Galaxy Watch6 ayaa soo saari doona dhamaadka Julaay. Ku cusboonaysii One UI 5 Watch waa in la sii daayo wax yar ka dib. Hal UI 5 kordhin Watch, kaas oo kooxda reer Kuuriya ay soo bandhigtay ugu dambeyntii usbuuca, waxay keeni doontaa, iyo waxyaabo kale, aagagga garaaca wadnaha ee shakhsi ahaaneed iyo hagaajinta sifooyinka badbaadada sida ogaanshaha dayrta iyo wicitaanada tooska ah ee SOS.

Waxaad ka iibsan kartaa saacadaha smart Samsung halkan

kan maanta loogu akhris badan yahay

.